Literature DB >> 20425251

The role of smoking cessation in the prevention of coronary artery disease.

Andrew L Pipe1, Sophia Papadakis, Robert D Reid.   

Abstract

Smoking (tobacco addiction) is the most significant of the modifiable cardiovascular risk factors. Mistakenly described as a "habit" or "behavioral choice," the onset of tobacco addiction quickly follows the acquisition of an ability to inhale cigarette smoke and is reflected in a transformation of neurophysiologic function and nicotine-receptor density. Thereafter, comfort and a degree of neurophysiologic "equanimity" require the regular administration of nicotine. Smokers inhale thousands of other chemicals, many of which play critical roles in the initiation and accentuation of atherosclerosis by influencing vasomotor activity, vascular dysfunction, oxidation of lipids, atheroma development, and thrombosis. Smoking cessation is a priority in the management of any patient with cardiovascular disease. The benefits of cessation accrue rapidly in such patients and have a pronounced effect on the likelihood of disease progression, hospital readmission, and mortality. All physicians must be familiar with the principles of cessation practice and be able to initiate smoking cessation attempts.

Entities:  

Mesh:

Year:  2010        PMID: 20425251     DOI: 10.1007/s11883-010-0105-8

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  43 in total

1.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.

Authors:  J A Suwaidi; S Hamasaki; S T Higano; R A Nishimura; D R Holmes; A Lerman
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

Review 2.  Individual behavioural counselling for smoking cessation.

Authors:  T Lancaster; L F Stead
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

Review 3.  Cardiovascular risks associated with smoking: a review for clinicians.

Authors:  Serena Tonstad; J Andrew Johnston
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2006-08

4.  Smoking cessation for hospitalized smokers: an evaluation of the "Ottawa Model".

Authors:  Robert D Reid; Kerri-Anne Mullen; Monika E Slovinec D'Angelo; Debbie A Aitken; Sophia Papadakis; Patricia M Haley; Christine A McLaughlin; Andrew L Pipe
Journal:  Nicotine Tob Res       Date:  2009-11-10       Impact factor: 4.244

5.  Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction.

Authors:  I S Ockene; N H Miller
Journal:  Circulation       Date:  1997-11-04       Impact factor: 29.690

6.  Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers.

Authors:  Y Fusegawa; S Goto; S Handa; T Kawada; Y Ando
Journal:  Thromb Res       Date:  1999-03-15       Impact factor: 3.944

7.  Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction.

Authors:  D E Newby; R A Wright; C Labinjoh; C A Ludlam; K A Fox; N A Boon; D J Webb
Journal:  Circulation       Date:  1999-03-23       Impact factor: 29.690

8.  Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women.

Authors:  A P Burke; A Farb; G T Malcom; Y Liang; J Smialek; R Virmani
Journal:  Circulation       Date:  1998-06-02       Impact factor: 29.690

Review 9.  Environmental tobacco smoke and ischemic heart disease.

Authors:  Malcolm R Law; Nicholas J Wald
Journal:  Prog Cardiovasc Dis       Date:  2003 Jul-Aug       Impact factor: 8.194

10.  Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial.

Authors:  Nancy A Rigotti; Andrew L Pipe; Neal L Benowitz; Carmen Arteaga; Dahlia Garza; Serena Tonstad
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

View more
  4 in total

1.  Atherosclerosis within the non-neoplastic margin of partial nephrectomy specimens: implications for medical management.

Authors:  Michael A Gorin; Michael Garcia-Roig; Monica Garcia-Buitrago; Carlos Parra-Herran; Merce Jorda; Gaetano Ciancio
Journal:  World J Urol       Date:  2012-11-28       Impact factor: 4.226

2.  Association of the rs10757274 SNP with coronary artery disease in a small group of a Pakistani population.

Authors:  Syed Kashif Nawaz; Aasma Noreen; Asima Rani; Memoona Yousaf; Muhammad Arshad
Journal:  Anatol J Cardiol       Date:  2015-01-07       Impact factor: 1.596

3.  Clustering of cardiovascular risk factors and carotid intima-media thickness: The USE-IMT study.

Authors:  Xin Wang; Geertje W Dalmeijer; Hester M den Ruijter; Todd J Anderson; Annie R Britton; Jacqueline Dekker; Gunnar Engström; Greg W Evans; Jacqueline de Graaf; Diederick E Grobbee; Bo Hedblad; Suzanne Holewijn; Ai Ikeda; Jussi Kauhanen; Kazuo Kitagawa; Akihiko Kitamura; Sudhir Kurl; Eva M Lonn; Matthias W Lorenz; Ellisiv B Mathiesen; Giel Nijpels; Shuhei Okazaki; Joseph F Polak; Jacqueline F Price; Christopher M Rembold; Maria Rosvall; Tatjana Rundek; Jukka T Salonen; Matthias Sitzer; Coen D A Stehouwer; Tomi-Pekka Tuomainen; Sanne A E Peters; Michiel L Bots
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240

4.  Years of life lost due to bladder cancer among the inhabitants of Poland in the years 2000 to 2014.

Authors:  Mateusz Jobczyk; Małgorzata Pikala; Waldemar Różański; Irena Maniecka-Bryła
Journal:  Cent European J Urol       Date:  2017-09-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.